Tempest Therapeutics, Inc. (TPST): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$295.0K
Year ended 2017-12-31
$653.0K2013-12-31: $02014-12-31: $02015-12-31: $277.0K2016-12-31: $653.0K2017-12-31: $295.0K$295.0K
2013-12-31 Revenue (USD) 2017-12-31
Period endedRevenueChange YoYSource filing
2017-12-31$295.0K-54.8%2018-03-15, From 2017-01-01
2016-12-31$653.0K+135.7%2018-03-15, From 2016-01-01
2015-12-31$277.0Kn/a2018-03-15, From 2015-01-01
2014-12-31$0n/a2017-03-02, From 2014-01-01
2013-12-31$0n/a2016-02-26, From 2013-01-01